GREGORY BREEN M.D. NPI 1538119961

NPI Details

Gregory Breen, M.D. is a pulmonary disease internal medicine in Woodbury, NJ with 32 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. Gregory Breen, M.D. NPI is 1538119961. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: DREXEL UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:1994

The provider's business location address is:

52 W RED BANK AVE
SUITE 26
WOODBURY, NJ
ZIP 08096-695
Phone: (856) 853-2025
Fax: (856) 845-8024

The NPI 1538119961 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Sleep study including heart rate, breathing, airflow, and effort (HCPCS:95806)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Sleep study in sleep lab (6 years or older) (HCPCS:95810)
• Sleep study in sleep lab with continuous airway pressure (6 years or older) (HCPCS:95811)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of vaccine (HCPCS:90471)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Test to measure the level of nitric oxide gas (HCPCS:95012)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Aspiration of initial secretion of lung airway using an endoscope (HCPCS:31645)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0221)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)

The enumeration date for this NPI number is 5/10/2006 and was last updated on 3/13/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.